Geron Corp. (GERN) Company Profile & Statistics

Geron Corp.
GERN
(Nasdaq - US)
Open
3.74
+0.08 (+2.19%)
in:usd•As of: Nov 18, 2024 12:38 UTC -5
Open
3.69
High
3.77
Low
3.61

About Geron Corp.

CEO

John A. Scarlett

Headquarters

919 east hillsdale boulevard, suite 250

foster city, ca 94404, united states

Auditor

Ernst & Young LLP

Employees

141

Share Holders

451

Website

www.geron.com

Industry

biotechnology

Sector

health technology

Company Overview

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.

Geron Corp. Statistics

Valuation Measures

Market Capitalization ²	2.26B
Enterprise Value	2.28B
Enterprise Value/EBITDA (ttm)	-10.63
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	7.55
Price to Sales (ttm)	75.05
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	99.11%
Operating Margin (ttm)	-682.48%
Profit Margin (ttm)	-62980.81%
Return on Equity (ttm)	-67.53%
Return on Invested Capital (ttm)	-62.24%
Return on Assets (ttm)	-45.46%

Income Statement

Revenue (ttm)	29.48M
Revenue Per Share (ttm)	0.05
Gross Profit (ttm)	29.01M
EBITDA (ttm)³	-214.68M
Net Income Avi to Common (ttm)	-201.19M
Diluted EPS (ttm)	-0.32

Share Statistics

Beta (5Y Monthly)	0.52
52-Week Change	86.07%
S&P500 52-Week Change	29.68%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	604.50M
Dividend Yield	0.00%
Float ⁴	586.37M
% Held by Insiders	3.00%
% Held by Institutions	73.71%

Balance Sheet

Total Cash (mrq)	341.63M
Total Cash Per Share (mrq)	0.57
Total Debt (mrq)	83.84M
Total Debt/Equity (mrq)	28.68%
Current Ratio (mrq)	2.89%
Quick Ratio (mrq)	2.74%
Book Value Per Share (mrq)	0.48

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.26
Free Cash Flow (ytd)	-175.49M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Geron Corp.

Trade With A Regulated Broker